CN104603291B - 黑素细胞病变中的分子恶性肿瘤 - Google Patents

黑素细胞病变中的分子恶性肿瘤 Download PDF

Info

Publication number
CN104603291B
CN104603291B CN201380045664.3A CN201380045664A CN104603291B CN 104603291 B CN104603291 B CN 104603291B CN 201380045664 A CN201380045664 A CN 201380045664A CN 104603291 B CN104603291 B CN 104603291B
Authority
CN
China
Prior art keywords
mir
sample
expression
biomarkers
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380045664.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104603291A (zh
Inventor
王慧
C·罗伯茨
K·马杜拉
陆振强
J·布朗
T·瓦西塞克
B·J·科恩斯
B·塞利格曼
D·S·B·胡恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wayne Cancer Institute
HTG Molecular Diagnostics Inc
Original Assignee
John Wayne Cancer Institute
HTG Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wayne Cancer Institute, HTG Molecular Diagnostics Inc filed Critical John Wayne Cancer Institute
Publication of CN104603291A publication Critical patent/CN104603291A/zh
Application granted granted Critical
Publication of CN104603291B publication Critical patent/CN104603291B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201380045664.3A 2012-06-22 2013-06-24 黑素细胞病变中的分子恶性肿瘤 Active CN104603291B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261663428P 2012-06-22 2012-06-22
US61/663,428 2012-06-22
PCT/US2013/047354 WO2013192616A1 (en) 2012-06-22 2013-06-24 Molecular malignancy in melanocytic lesions

Publications (2)

Publication Number Publication Date
CN104603291A CN104603291A (zh) 2015-05-06
CN104603291B true CN104603291B (zh) 2018-04-06

Family

ID=49769469

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380045664.3A Active CN104603291B (zh) 2012-06-22 2013-06-24 黑素细胞病变中的分子恶性肿瘤

Country Status (7)

Country Link
US (1) US9758829B2 (https=)
EP (1) EP2864500B1 (https=)
JP (1) JP6366580B2 (https=)
CN (1) CN104603291B (https=)
AU (1) AU2013277971B2 (https=)
CA (1) CA2875710C (https=)
WO (1) WO2013192616A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014149629A1 (en) * 2013-03-15 2014-09-25 Htg Molecular Diagnostics, Inc. Subtyping lung cancers
US11021752B2 (en) * 2013-03-15 2021-06-01 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
JP6496899B2 (ja) * 2014-07-01 2019-04-10 公立大学法人福島県立医科大学 浸潤性髄膜腫判別用試薬、及びその判別方法
EP3164508B1 (en) * 2014-07-02 2023-06-07 Myriad myPath, LLC Genes and gene signatures for diagnosis and treatment of melanoma
EP3218521B1 (en) * 2014-11-12 2019-12-25 Hitachi Chemical Co., Ltd. Method for diagnosing organ injury
WO2016152352A1 (ja) * 2015-03-20 2016-09-29 国立大学法人名古屋大学 メラノーマ特異的バイオマーカー及びその利用
GB2544834A (en) * 2015-06-09 2017-05-31 Waters Technologies Corp Profile diagnositcs in personalized dermatology, dermatopathology and cosmetics
GB2565238A (en) * 2015-06-09 2019-02-06 Waters Technologies Corp Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics
CN107636678B (zh) * 2015-06-29 2021-12-14 北京市商汤科技开发有限公司 用于预测图像样本的属性的方法和设备
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
JP7354099B2 (ja) * 2017-10-03 2023-10-02 ジェネシーク ピーティーワイ リミテッド マイクロｒｎａ遺伝子発現を使用して黒色腫を診断し、病期分類し、モニタリングする方法
US20210012214A1 (en) * 2018-03-29 2021-01-14 Nec Corporation Learning apparatus, learning method, and computer-readable recording medium
CN108537005B (zh) * 2018-04-03 2019-04-02 福州大学 一种基于BPSO-KNN模型的关键lncRNA预测方法
JP7526100B2 (ja) 2018-05-31 2024-07-31 バークレー ライツ，インコーポレイテッド マイクロ流体デバイスによる微小物体の自動検出及び特徴付け
US11017896B2 (en) * 2018-06-28 2021-05-25 Case Western Reserve University Radiomic features of prostate bi-parametric magnetic resonance imaging (BPMRI) associate with decipher score
FR3085825B1 (fr) 2018-09-14 2021-07-16 Fermentalg Huile de microorganismes riche en acide docosahexaenoique
FR3085962B1 (fr) 2018-09-14 2021-06-18 Fermentalg Procede d'extracton d'une huile riche en pufa
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
CN112513891B (zh) * 2019-01-02 2025-12-05 松下电器（美国）知识产权公司 信息处理装置、信息处理方法及记录介质
CN114693646B (zh) * 2022-03-31 2023-04-11 中山大学中山眼科中心 一种基于深度学习的角膜内皮细胞活性因子的分析方法
JP7806660B2 (ja) * 2022-11-11 2026-01-27 コニカミノルタ株式会社 検出方法
WO2024108191A1 (en) * 2022-11-18 2024-05-23 University Of Virginia Patent Foundation Machine learning approach to predicting lymph node metastases
CN117625632A (zh) * 2024-01-22 2024-03-01 中国医学科学院北京协和医院 肌萎缩侧索硬化症的SQSTM1的p.L382CfsTer13突变致病基因及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062199A1 (en) * 2007-11-09 2009-05-14 Fox Chase Cancer Center EGFR/NEDD9/TGF-β LNTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
WO1985001051A1 (en) 1983-09-02 1985-03-14 Molecular Biosystems, Inc. Oligonucleotide polymeric support system
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5219727A (en) 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5554501A (en) 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0758403B1 (en) 1994-05-05 1998-06-24 Beckman Instruments, Inc. Oligonucleotide repeat arrays
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5736330A (en) 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
US5716784A (en) 1996-02-05 1998-02-10 The Perkin-Elmer Corporation Fluorescence detection assay for homogeneous PCR hybridization systems
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5985567A (en) 1997-08-15 1999-11-16 Beckman Coulter, Inc. Hybridization detection by pretreating bound single-stranded probes
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US6013789A (en) 1998-02-20 2000-01-11 Beckman Coulter, Inc. Covalent attachment of biomolecules to derivatized polypropylene supports
AU2375600A (en) 1998-12-22 2000-07-12 Stephen Felder High throughput assay system using mass spectrometry
WO2000066265A2 (en) 1999-04-27 2000-11-09 Ciphergen Biosystems, Inc. Probes for a gas phase ion spectrometer
EP1410011B1 (en) 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnosis and prognosis of breast cancer patients
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
JP2007527247A (ja) 2004-03-05 2007-09-27 ロゼッタ インファーマティクス エルエルシー 臨床的基準および情報提供性遺伝子セットの組合せを使用する乳癌患者の分類
BRPI0512587A (pt) 2004-06-25 2007-09-18 Veridex Llc processo e reagentes para detecção de melanoma
CN101687022B (zh) 2007-03-26 2016-09-07 莱顿大学医学中心附属莱顿教学医院 Prame衍生的肽以及包括该肽的免疫原组合物
US20080268451A1 (en) 2007-03-30 2008-10-30 Bruce Seligmann Measurement of an insoluble analyte in a sample
WO2009099905A2 (en) * 2008-02-01 2009-08-13 Memorial Health Inc. Molecular signatures and biomarkers associated with melanoma and methods of use thereof
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
EP2619332A4 (en) 2010-09-22 2014-04-16 Dave S B Hoon DIRECT BLOOD ASSAY TO DETECT MICROARN CIRCULATING IN PATIENTS WITH CANCER
ES2597032T3 (es) 2011-05-04 2017-01-13 HTG Molecular Diagnostics, Inc Mejoras en un ensayo cuantitativo de protección contra la nucleasa (qNPA) y secuenciación (qNPS)
AU2012316129B2 (en) 2011-09-28 2017-10-05 Htg Molecular Diagnostics, Inc. Methods of co-detecting mRNA and small non-coding RNA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062199A1 (en) * 2007-11-09 2009-05-14 Fox Chase Cancer Center EGFR/NEDD9/TGF-β LNTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Genechip Human Genome Arrays;Affymetrix;《Affymetrix Datasheet》;20030812;全文 *

Also Published As

Publication number Publication date
CN104603291A (zh) 2015-05-06
EP2864500B1 (en) 2018-08-22
AU2013277971B2 (en) 2018-11-15
WO2013192616A1 (en) 2013-12-27
CA2875710C (en) 2021-06-29
EP2864500A1 (en) 2015-04-29
CA2875710A1 (en) 2013-12-27
US9758829B2 (en) 2017-09-12
JP6366580B2 (ja) 2018-08-01
AU2013277971A1 (en) 2015-01-29
US20150176072A1 (en) 2015-06-25
JP2015521483A (ja) 2015-07-30
EP2864500A4 (en) 2016-07-13

Similar Documents

Publication Publication Date Title
CN104603291B (zh) 黑素细胞病变中的分子恶性肿瘤
US20160019337A1 (en) Subtyping lung cancers
EP1934615B1 (en) Methods and materials for identifying the origin of a carcinoma of unknown primary origin
JP6404304B2 (ja) メラノーマ癌の予後予測
CN104603292A (zh) 用于提供前列腺癌的临床评估的方法、试剂盒和组合物
EP1899484B1 (en) Identification of tumors and tissues
KR20150005726A (ko) 직장결장암용 예후 예측
CN111183235A (zh) 使用微rna基因表达来对黑素瘤进行诊断、分期和监测的方法
US20060134671A1 (en) Methods and systems for prognosis and treatment of solid tumors
CN112921083A (zh) 肠道息肉和结直肠癌评价中的基因标志物
Stolf et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression
JP2026503720A (ja) 前立腺がんの予後予測、診断及び治療に有用なキット及び方法
US10066270B2 (en) Methods and kits used in classifying adrenocortical carcinoma
HK1237068B (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
HK1182452B (en) Methods and compositions for diagnosing conditions
HK1182452A1 (zh) 用於诊断病状的方法和组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant